Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy ...Middle East

ROME and MILAN, Jan. 14, 2025 /PRNewswire/ -- Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics. Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that...

Read More Details
Finally We wish PressBee provided you with enough information of ( Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy )

Also on site :

• Bodies of two Israeli-American hostages recovered from Gaza in joint military operation
• Second interview with AUC professor Bahgat Korany discusses Suez Canal, GERD concerns & global politics
• Philadelphia Cream Cheese Shakes Up Classic Recipe With Limited-Edition Offer